HIGHLINE WEALTH PARTNERS LLC
Position in DRMA — Dermata Therapeutics, Inc.
CIK 2042654
SHERMAN OAKS, CA
Position in DRMA
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$33
New position
Shares Held
26
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 13 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026HIGHLINE WEALTH PARTNERS LLC holds $984,033 across 14 Biotechnology names. DRMA ranks #14 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,739 | $863,813 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
1,000 | $54,540 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
20 | $12,470 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
48 | $11,566 | |
| 5 | EXEL |
Exelixis, Inc.
|
201 | $10,936 | |
| 6 | TECH |
BIO-TECHNE Corp
|
128 | $9,043 | |
| 7 | INCY |
Incyte Corp
|
65 | $7,368 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
18 | $5,418 |
All Filings in DRMA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33 | 26 | Shares | Sole | 2026-07-15 | |
| No filing history on record for this holder in this stock. | ||||||